The Healthcare Industry Needs a Course Correction

By STEVEN ZECOLA The United States healthcare system has failed by any measure. First, costs are out of control. For example, 17% of the country’s GDP is spent on healthcare. This percentage was less than half that amount in 1980. It is expected to continue growing to 20% by 2032. Seventy-five percent of these costs are attributable to…

Read More

What makes a drug “special”?

A recent paper by Kacerek and Mattingly (2025) aims to answer why certain drugs are defined as “specialty” drugs and others are not. They first cite an Office of the Inspector General (OIG) report: The OIG found that there was no standard definition in Medicaid and that Medicaid programs used more than 100 different characteristics to…

Read More

The ICHRA Moment Is Here — Are You Ready for It?

ICHRA is surging in popularity as an option for employer-sponsored insurance to access the individual market, as employers rethink traditional group plans with unpredictable renewal rates and employees seek personalized healthcare. Here’s a closer look at why investors and politicians are eyeing ICHRA. The post The ICHRA Moment Is Here — Are You Ready for It?…

Read More